跳到主要內容

Iannone Robert 的 Form 4 申報

Jazz Pharmaceuticals plc(JAZZ),2026/8/31 申報

申報編號
0001737329-26-000016
申報時間
2026/8/31 18:45 ET
交易日
2026/8/27
申報延遲
4 天
10b5-1 計畫
有勾選

這份申報列了 10 筆非衍生性交易、4 筆衍生性交易。公開市場賣出合計 $1,921 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Iannone RobertCIK 0001737329高階主管(EVP, Global Head of R&D & CMO)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/8/27Ordinary SharesM行使選擇權取得+26,116$113.10+$2,953,719.6111,223直接
2026/8/27Ordinary SharesM行使選擇權取得+884$113.10+$99,980.4112,107直接
2026/8/27Ordinary SharesM行使選擇權取得+27,584$137.12+$3,782,318.08139,691直接
2026/8/27Ordinary SharesM行使選擇權取得+2,916$137.12+$399,841.92142,607直接
2026/8/27Ordinary SharesS賣出處分−18,187$247.86F2−$4,507,780.72124,420直接
2026/8/27Ordinary SharesS賣出處分−11,423$248.67F3−$2,840,516.29112,997直接
2026/8/27Ordinary SharesS賣出處分−18,113$250.02F4−$4,528,572.4194,884直接
2026/8/27Ordinary SharesS賣出處分−19,639$250.60F5−$4,921,596.2475,245直接
2026/8/27Ordinary SharesS賣出處分−9,259$251.95F6−$2,332,804.1265,986直接
2026/8/27Ordinary SharesS賣出處分−300$252.76−$75,82865,686直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2026/8/27Ordinary SharesM行使選擇權處分−884$0.00$00直接
2026/8/27Ordinary SharesM行使選擇權處分−2,916$0.00$00直接
2026/8/27Ordinary SharesM行使選擇權處分−26,116$0.00$00直接
2026/8/27Ordinary SharesM行使選擇權處分−27,584$0.00$00直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $247.29 to $248.24. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

表 I 有 1 筆交易的價格引用這則附註。

F3

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $248.29 to $249.24. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

表 I 有 1 筆交易的價格引用這則附註。

F4

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $249.33 to $250.325 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

表 I 有 1 筆交易的價格引用這則附註。

F5

Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $250.33 to $251.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

表 I 有 1 筆交易的價格引用這則附註。

F6

Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $251.37 to $252.31. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)